The main focus of this work was to analyze the possible implication of Lipocalin-2 (Lcn-2) upregulation for the course of ischemia=reperfusion (IR) during heart transplantation as well as its role in acute allograft rejection. Lcn-2 expression was also analyzed in terms of acute rejection following liver transplantation in a clinical setting.
Background: The main focus of this work was to analyze the possible implication of Lipocalin-2 (Lcn-2) upregulation for the course of ischemia=reperfusion (IR) during heart transplantation as well as its role in acute allograft rejection. Lcn-2 expression was also analyzed in terms of acute rejection following liver transplantation in a clinical setting.
Methods: Male inbred C3H and C57BL=6 mice as well as the Lcn-2À=À mouse were used in our transplantation experiments. Western blot, RT-PCR and immunohistochemistry and TUNEL assay were performed to determine Lcn-2 expression and apoptosis in the graft. Cardiac rejection was classified following the ISHLT score (0-3). Additionally, Lcn-2 protein expression was analyzed in the serum of recipients at day 0-15 following liver transplantation using ELISA technology.
Results: Infiltrating polymorphonuclear cells (PMN) were the major contributors to Lcn-2 expression during IR peaking 24 h after reperfusion. The number of infiltrating PMN was significantly reduced in Lcn-2À=À recipients (by 79% at 12 h [p < 0.01]). No difference was observed in the apoptotic rate between wildtype and Lcn-2À=À donors in our murine heart transplantation model. Concomitant upregulation of Lcn-2 in the serum of liver transplant recipients could be observed during acute rejection episodes in a timely dependent course (3 to 7-fold).
Conclusions: Our data suggest a chemoattractant function of increased Lcn-2 expression in the transplanted heart due to infiltrating PMN. Lcn-2 is a novel inflammatory regulator upregulated during IR and is proposed an early biomarker for acute graft rejection. Our observations shed light on a possible function of Lcn-2 in the recruitment of PMN to the site of IR and identify possible targets for therapeutic intervention.
